Condition: Gallbladder Cancer · Sponsor: Banaras Hindu University
Evidence suggests distinct models of molecular and pathologic progression, and a growing body of genetics data points to a heterogeneous collection of underlying mutations in key oncogenes and tumor suppressor genes. Although tumor genetics have been used to tailor individual treatment regimens and guide clinical decision making in other cancers, these principles have not been applied in gallbladder malignancy. Recent clinical trials with targeted therapies seem promising, although the relationships between subsets of patients with positive responses to therapy and tumor genetics remain unexplored.
This description comes directly from the study's public registry record.
Manoj Pandey, MS, PhD · 2361014 · mpandey66@bhu.ac.in
S K Singh, MD, DM · 2361014 · mdean.ims@gmail.com
Always discuss trial participation with your own doctor first.
| Banaras Hindu University | Varanasi, Uttar Pradesh, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05404347